Menopause, but not age, is an independent risk factor for fasting plasma glucose levels in nondiabetic women

Menopause

Volumn 14, Issue 3, 2007, Pages 404-407

  Otsuki, Michio ^a   Kasayama, Soji ^a   Morita, Shinya ^a   Asanuma, Nobuyuki ^a   Saito, Hiroshi ^b   Mukai, Mikio ^b   Koga, Masafumi ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

Author keywords

Diabetes; Glucose metabolism; Menopause; Women's health

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGING; ARTICLE; BLOOD; BODY MASS; CORONARY ARTERY DISEASE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; JAPAN; MENOPAUSE; METABOLISM; MIDDLE AGED; REFERENCE VALUE; REGRESSION ANALYSIS; RISK FACTOR; WOMEN'S HEALTH;

ADULT; AGING; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; JAPAN; MENOPAUSE; MIDDLE AGED; REFERENCE VALUES; REGRESSION ANALYSIS; RISK FACTORS; TRIGLYCERIDES; WOMEN'S HEALTH;

EID: 34447272474     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/01.gme.0000247014.56254.12     Document Type: Article

References (27)

1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-1197.
2. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-3167.
3. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002;19:708-723.
4. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, Switzerland: World Health Organization, 1999. Available at: http://whqlibdoc.who.int/hq/1999/who- ncd-ncs-99.2.pdf. Accessed March 30, 2000.
5. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421.
6. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005;366:1059-1062.
7. Tirosh A, Shai I, Tekes-Manova D, et al, for the Israeli Diabetes Research Group. Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 2005;353:1454-1462.
8. Zimmet P, Whitehouse S. The effect of age on glucose tolerance: studies in the Polynesian population of Funafuti. Acta Diabetol Lat 1982;19:65-74.
9. Goodman-Gruen D, Barrett-Connor E. Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care 2000;23:912-918.
10. Galipeau DM, Yao L, McNeill JH. Relationship among hyperinsulinemia, insulin resistance, and hypertension is dependent on sex. Am J Physiol Heart Circ Physiol 2002;283:H562-H567.
11. Otsuki M, Kasayama S, Saito H, Mukai M, Koga M. Sex differences of age-dependent changes of insulin sensitivity in Japanese nondiabetic subjects. Diabetes Care 2005;28:2590-2591.
12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
13. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998;21:2191-2192.
14. Tanne D, Koren-Morag N, Goldbourt U. Fasting plasma glucose and risk of incident ischemic stroke or transient ischemic attacks: a prospective cohort study. Stroke 2004;35:2351-2355.
15. Simons LA, Friedlander Y, McCallum J, Simons J. Fasting plasma glucose in non-diabetic elderly women predicts increased all-causes mortality and coronary heart disease risk. Aust N Z J Med 2000;30:41-47.
16. Wu SI, Chou P, Tsai ST. The impact of years since menopause on the development of impaired glucose tolerance. J Clin Epidemiol 2001;54:117-120.
17. Kanaya AM, Herrington D, Vittinghoff E, et al. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2003;138:1-9.
18. Friday KE, Dong C, Fontenot RU. Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 2001;86:48-52.
19. Kimmerle R, Heinemann L, Heise T, et al. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women. Menopause 1999;6:36-42.
20. Vehkavaara S, Westerbacka J, Hakala-Ala-Pietilä T, Virkamäki A, Hovatta O, Yki-Järvinen H. Effect of estrogen replacement therapy on insulin sensitivity of glucose metabolism and preresistance and resistance vessel function in healthy postmenopausal women. J Clin Endocrinol Metab 2000;85:4663-4670.
21. Smith EP, Boyd J, Frank GR, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994;331:1056-1061.
22. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995;80:3689-3698.
23. Bilezikian JP, Morishima A, Bell J, Grumbach MM. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 1998;339:599-603.
24. Luoto R, Sharrett AR, Schreiner P, Sorlie PD, Arnett D, Ephross S. Blood pressure and menopausal transition: the Atherosclerosis Risk in Communities study (1987Y95). J Hypertens 2000;18:27-33.
25. Arca M, Vega GL, Grundy SM. Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin. JAMA 1994;271:453-459.
26. Ikenoue N, Wakatsuki A, Okatani Y. Small low-density lipoprotein particles in women with natural or surgically induced menopause. Obstet Gynecol 1999;93:566-570.
27. Lipid Research Clinics Program Epidemiology Committee. Plasma lipid distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. Circulation 1979;60:427-439.